SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1492.00-47.6 (-3.09 %)
PREV CLOSE ( ) 1539.60
OPEN PRICE ( ) 1560.05
BID PRICE (QTY) 1491.25 (15)
OFFER PRICE (QTY) 1492.15 (48)
VOLUME 33968
TODAY'S LOW / HIGH ( )1485.10 1560.70
52 WK LOW / HIGH ( )922.55 1638.7
NSE1493.00-47.1 (-3.06 %)
PREV CLOSE( ) 1540.10
OPEN PRICE ( ) 1562.00
BID PRICE (QTY) 1493.00 (175)
OFFER PRICE (QTY) 1493.05 (4)
VOLUME 2129129
TODAY'S LOW / HIGH( ) 1485.05 1562.45
52 WK LOW / HIGH ( )922.45 1638.85
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.